http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20716777

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 107
issn 0014-4886
issueIdentifier 1
pageRange 101-107
publicationName Experimental Neurology
startingPage 101
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_89dc7f241d493e55a9857f0cb017ae65
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f230189f7ac36d53e3be065700e6e896
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a15ef31565f10a245d18093a4e65d7d3
bibliographicCitation COX H, TOGASAKI D, CHEN L, LANGSTON J, DIMONTE D, QUIK M. The selective κ-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Experimental Neurology. 2007 May;205(1):101–7. doi: 10.1016/j.expneurol.2007.01.024.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e3df5aefe792ddb1caa355f5d80035
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5f6e914e9b5ac5d74c6b2130adf771f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75e6d378f473f57ce77fe6f62eb21f45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14d8fedb26fb6313727a90017ed9a076
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d30f58fb4e1e1a0fc2c5fd9ac9a092d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcc2ad8d236a4f642e37efb9a1508042
date 200705
identifier https://doi.org/10.1016/j.expneurol.2007.01.024
https://pubmed.ncbi.nlm.nih.gov/17335811
https://pubmed.ncbi.nlm.nih.gov/PMC2001245
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3660
https://portal.issn.org/resource/ISSN/0014-4886
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates
discusses http://id.nlm.nih.gov/mesh/M0023971
http://id.nlm.nih.gov/mesh/M0001494
http://id.nlm.nih.gov/mesh/M0010885
http://id.nlm.nih.gov/mesh/M0023499
http://id.nlm.nih.gov/mesh/M0012434
http://id.nlm.nih.gov/mesh/M0026510
http://id.nlm.nih.gov/mesh/M0029556
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020734Q000139
http://id.nlm.nih.gov/mesh/D015632
http://id.nlm.nih.gov/mesh/D004409Q000503
http://id.nlm.nih.gov/mesh/D007980Q000037
http://id.nlm.nih.gov/mesh/D020734Q000503
http://id.nlm.nih.gov/mesh/D015259
http://id.nlm.nih.gov/mesh/D019900Q000494
http://id.nlm.nih.gov/mesh/D017473Q000819
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006993Q000494
http://id.nlm.nih.gov/mesh/D012453
http://id.nlm.nih.gov/mesh/D017207
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D014839Q000139
http://id.nlm.nih.gov/mesh/D000978Q000037
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D019900Q000008
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55ee4087dfa88c9d131f9b5b4d14584a
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8519

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128934001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129512383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235

Total number of triples: 69.